Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

Similar articles for PubMed (Select 23527477)

1.

Introduction to the 50th anniversary of the description of alpha-1 antitrypsin deficiency.

Sandhaus RA, Stoller JK.

COPD. 2013 Mar;10 Suppl 1:1-2. doi: 10.3109/15412555.2013.765840. No abstract available.

PMID:
23527477
2.

alpha(1)-antitrypsin deficiency therapy : pieces of the puzzle.

Sandhaus RA.

Chest. 2001 Mar;119(3):676-8. No abstract available.

PMID:
11243938
3.

[Substitution therapy in alpha 1-antitrypsin deficiency].

Konietzko N.

Pneumologie. 2001 Jan;55(1):1-3. German. No abstract available.

PMID:
11236351
4.

Case detection of alpha1-antitrypsin deficiency: does it help the patient or the doctor?

Stolk J.

Eur Respir J. 2005 Oct;26(4):561-2. No abstract available.

5.

Alpha1-antitrypsin replacement therapy controls fibromyalgia symptoms in 2 patients with PI ZZ alpha1-antitrypsin deficiency.

Blanco I, Canto H, de Serres FJ, Fernandez-Bustillo E, Rodríguez MC.

J Rheumatol. 2004 Oct;31(10):2082-5.

PMID:
15468381
6.

Emerging drugs for alpha-1-antitrypsin deficiency.

Stockley RA.

Expert Opin Emerg Drugs. 2010 Dec;15(4):685-94. doi: 10.1517/14728214.2010.512287. Epub 2010 Aug 18. Review.

PMID:
20716026
7.

[Hereditary alpha-1-antitrypsin deficiency can cause COPD. Substitution treatment seems to result in fewer infections and prolonged survival].

Janciauskiene S.

Lakartidningen. 2007 Nov 28-Dec 4;104(48):3631-4, 3637-8. Review. Swedish. No abstract available.

PMID:
18193673
8.

Alpha1-antitrypsin augmentation therapy.

Pierce JA.

Chest. 1997 Oct;112(4):872-4. No abstract available.

PMID:
9377947
9.
10.

Alpha-1 antitrypsin deficiency: the European experience.

Stockley RA, Dirksen A, Stolk J.

COPD. 2013 Mar;10 Suppl 1:50-3. doi: 10.3109/15412555.2013.765838. Review.

PMID:
23527820
11.

Alpha-1 antitrypsin deficiency: pathogenesis, clinical presentation, diagnosis, and treatment.

Köhnlein T, Welte T.

Am J Med. 2008 Jan;121(1):3-9. doi: 10.1016/j.amjmed.2007.07.025. Review.

PMID:
18187064
12.

Key current clinical issues in alpha-1 antitrypsin deficiency.

Stoller JK.

Respir Care. 2003 Dec;48(12):1216-21; discussion 1221-4. Review.

13.

Augmentation therapy for alpha(1)-antitrypsin deficiency.

Juvelekian GS, Stoller JK.

Drugs. 2004;64(16):1743-56. Review.

PMID:
15301559
14.

Severe panniculitis caused by homozygous ZZ alpha1-antitrypsin deficiency treated successfully with human purified enzyme (Prolastin).

Chowdhury MM, Williams EJ, Morris JS, Ferguson BJ, McGregor AD, Hedges AR, Stamatakis JD, Pope FM.

Br J Dermatol. 2002 Dec;147(6):1258-61.

PMID:
12452881
15.

Augmentation therapy in alpha(1)-antitrypsin deficiency.

Burdon JG, Brenton S, Ayad M, Knight K.

Chest. 2001 Aug;120(2):687. No abstract available.

PMID:
11502686
17.

A novel model and molecular therapy for Z alpha-1 antitrypsin deficiency.

McNab GL, Dafforn TR, Wood A, Sapey E, Stockley RA.

Mamm Genome. 2012 Apr;23(3-4):241-9. doi: 10.1007/s00335-011-9370-2. Epub 2011 Nov 11.

PMID:
22076419
18.

Augmentation therapy in alpha-1 antitrypsin deficiency.

Heresi GA, Stoller JK.

Expert Opin Biol Ther. 2008 Apr;8(4):515-26. doi: 10.1517/14712598.8.4.515 . Review.

PMID:
18352854
19.

alpha1-Antitrypsin augmentation therapy for PI*MZ heterozygotes: a cautionary note.

Sandhaus RA, Turino G, Stocks J, Strange C, Trapnell BC, Silverman EK, Everett SE, Stoller JK; Medical and Scientific Advisory Committee of the Alpha-1 Foundation.

Chest. 2008 Oct;134(4):831-4. doi: 10.1378/chest.08-0868. Review.

PMID:
18842915
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk